-
-
-
-
-
-
-
HSBC upgrades Dr Reddy’s on weight loss drug semaglutide-driven earnings rebound
-
-
-
-
-
-
-
Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) PT Raised to INR1,620 at BofA Securities
-
-
-
-
-
-
-
Dr. Reddy’s Q3 & 9M FY24 Financial Results
-
-
-
-
-
-
-
Coya Therapeutics, Inc. Provides Business Update and Reports Q1 2023 Unaudited Financial Results
-
-
-
-
-
-
-
UPDATE: Barclays Upgrades Dr. Reddy's Laboratories (RDY) to Overweight
-
-
-
-
-
-
-
Dr. Reddy’s Q1 FY21 Financial Results
-
-
-
-
-
-
-
Dr. Reddy's to release Q2 FY 20 results on November 1, 2019
-
1,198,516 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

